ArticleNature2022
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection.
Abstract readPublished Erratum
In one paragraph
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SARS-CoV-2 lineage-dependent temporal phylogenetic distribution and viral load in immunocompromised and immunocompetent individuals.Virology journal · 2025Article
- UnCoVar: a reproducible and scalable workflow for transparent and robust virus variant calling and lineage assignment using SARS-CoV-2 as an example.BMC genomics · 2024Article
- Article
Corrections and comments
- Erratum for
Authors and funding
37 authors.
Steven A Kemp *Division of Infection and Immunity, University College London, London, UK.
Dami A Collier *Division of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0001-5446-4423
Rawlings P Datir *Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
Isabella A T M FerreiraCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
Salma GayedDepartment of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Aminu JahunDepartment of Pathology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-4585-1701
Myra HosmilloDepartment of Pathology, University of Cambridge, Cambridge, UK.
Chloe Rees-SpearDivision of Infection and Immunity, University College London, London, UK.
Petra MlcochovaCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
Ines Ushiro LumbNHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK.
David J RobertsNHS Blood and Transplant, Oxford and BRC Haematology Theme, University of Oxford, Oxford, UK.
Anita ChandraCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
Nigel TempertonViral Pseudotype Unit, Medway School of Pharmacy, University of Kent, Canterbury, UK.ORCID http://orcid.org/0000-0002-7978-3815
CITIID-NIHR BioResource COVID-19 Collaboration
COVID-19 Genomics UK (COG-UK) Consortium
Katherine SharrocksDepartment of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Elizabeth BlaneDepartment of Medicine, University of Cambridge, Cambridge, UK.
Yorgo ModisCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.ORCID http://orcid.org/0000-0002-6084-0429
Kendra E LeighCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
John A G BriggsMedical Research Council Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0003-3990-6910
Marit J van GilsDepartment of Medical Microbiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Kenneth G C SmithCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK.
John R BradleyDepartment of Medicine, University of Cambridge, Cambridge, UK.
Chris SmithDepartment of Virology, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Rainer DoffingerDepartment of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Lourdes Ceron-GutierrezDepartment of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
Gabriela Barcenas-MoralesDepartment of Clinical Biochemistry and Immunology, Addenbrooke's Hospital, Cambridge, UK.
David D PollockBiochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, USA.
Richard A GoldsteinDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0001-5148-4672
Anna SmielewskaDepartment of Pathology, University of Cambridge, Cambridge, UK.
Jordan P SkittrallDepartment of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0002-8228-3758
Theodore GouliourisDepartment of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.
Ian G GoodfellowDepartment of Pathology, University of Cambridge, Cambridge, UK.
Effrossyni Gkrania-KlotsasDepartment of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK.ORCID http://orcid.org/0000-0002-0930-8330
Christopher J R IllingworthDepartment of Applied Mathematics and Theoretical Physics, University of Cambridge, Cambridge, UK.
Laura E McCoyDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0001-9503-7946
Ravindra K GuptaCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. rkg20@cam.ac.uk.ORCID http://orcid.org/0000-0001-9751-1808
Funding
Medical Research Council MR/R008698/1Wellcome Trust 217191
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.